Parallax Volatility Advisers’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Parallax Volatility Advisers’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-75,000	Closed	-$1.33M	–	4455
2018 Q3	$1.33M	Buy	+75,000	New	+$1.29M	﹤0.01%	1171
2017 Q3	–	Sell	-6,000	Closed	-$9K	–	3740
2017 Q2	$9K	Sell	6,000 -51,500	-90%	-$111K	﹤0.01%	2000
2017 Q1	$148K	Buy	+57,500	New	+$133K	﹤0.01%	2091

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Parallax Volatility Advisers's ECYT Position: Q3 2018 in Review

Parallax Volatility Advisers sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2018, closing a stake of 1,504 shares — an estimated $25.8K sold.

Parallax Volatility Advisers first reported a position in ECYT in Q1 2017 and held it in 5 quarters. The position peaked at $132K in Q2 2017. 139 funds tracked by Wall St. Rank hold ECYT as of Q3 2018.

Parallax Volatility Advisers reported no remaining Endocyte, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 1,504 Endocyte, Inc. Common Stock shares in Q3 2018, an estimated $25.8K.
Parallax Volatility Advisers first reported a position in Endocyte, Inc. Common Stock in Q1 2017 and held it in 5 quarters.
Parallax Volatility Advisers's Endocyte, Inc. Common Stock position peaked at $132K in Q2 2017.
139 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2018.

Based on Parallax Volatility Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.